ScholarWorks@Korea University

Current filters:
Current filters:
Current filters:
Current filters:
Add filters:

Results 1-10 of 14 (Search time: 0.543 seconds).

SCIESCOPUSKCI
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment

Lee, Jung Hyun; Kang, Sung Gu; Kim, Seung Tae; Kang, Seok Ho; Choi, In Keun; Park, Young Je; Oh, Sang Chul; Sung, Deuk Jae; Seo, Jae Hong; Cheon, Jun, et al.

ArticleIssue Date2014CitationCANCER RESEARCH AND TREATMENT, v.46, no.2, pp.172 - 177PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUSKCI
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?

Kim, Seung Tae; Park, Kyong Hwa; Shin, Sang Won; Kim, Yeul Hong

ArticleIssue Date2014CitationCANCER RESEARCH AND TREATMENT, v.46, no.1, pp.48 - 54PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy

Yoon, Young Kyung; Kim, Min Ja; Sohn, Jang Wook; Kim, Hye Suk; Choi, Yoon Ji; Kim, Jung Sun; Kim, Seung Tae; Park, Kyong Hwa; Kim, Seok Jin; Kim, Byung Soo, et al.

ArticleIssue Date2014CitationSUPPORTIVE CARE IN CANCER, v.22, no.8, pp.2039 - 2048PublisherSPRINGER
SCIESCOPUS
Selection of a Patient Subgroup with Advanced Esophageal Squamous Carcinoma Who Could Benefit from Second-Line Chemotherapy

Kim, Seung Tae; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2010CitationONCOLOGY, v.79, no.5-6, pp.363 - 369PublisherKARGER
SCIESCOPUS
Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Kim, Seung Tae; Choi, Yoon Ji; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2011CitationCHEMOTHERAPY, v.57, no.2, pp.108 - 114PublisherKARGER
SCIESCOPUSKCI
Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

Kim, Seung Tae; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Kim, Jun Suk; Kim, Yeul Hong; Shin, Sang Won

ArticleIssue Date2012CitationCANCER RESEARCH AND TREATMENT, v.44, no.1, pp.37 - 42PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy

Kim, Seung Tae; Choi, Yoon Ji; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2012CitationCLINICAL ONCOLOGY, v.24, no.2, pp.105 - 111PublisherELSEVIER SCIENCE LONDON
SCIESCOPUS
The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients

Choi, Yoon Ji; Kim, Seung Tae; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2012CitationMEDICAL ONCOLOGY, v.29, no.2, pp.582 - 588PublisherHUMANA PRESS INC
SCIESCOPUS
Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients

Kim, Seung Tae; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2012CitationONCOLOGY, v.82, no.2, pp.126 - 130PublisherKARGER
SCIESCOPUS
Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?

Kim, Seung Tae; Park, Kyong Hwa; Oh, Sang Cheul; Seo, Jae Hong; Shin, Sang Won; Kim, Jun Suk; Kim, Yeul Hong

ArticleIssue Date2012CitationASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, v.8, no.2, pp.194 - 200PublisherWILEY-BLACKWELL
1 2

Discover

Date Issued

Type

Language

Journal Index

STATISTICS
Total View :7,719,570
Today View :2,917

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

COPYRIGHT © 2021 Korea University. All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어